Cancer partnership brings you the latest oncology clinical trials
The Nancy N. and J.C. Lewis Cancer & Research Pavilion is part of a state-wide consortium selected by the National Cancer Institute as part of the NCI Community Oncology Research Program.
What does that mean for you?
We know that 85 percent of cancer patients in the United States are diagnosed in or near the communities in which they live, which tells us that easier access to care is critical. Because of our participation in the NCI Community Oncology Research Program (NCORP), we have access to some of the latest cancer trials.
Very simply, this partnership means that cancer patients will not have to travel long distances or leave loved ones to take part in an NCI-sponsored trial.
Historically, many breakthroughs in cancer research have happened because of collaboration.
What is this collaboration?
The Lewis Cancer & Research Pavilion and Northside Hospital in Atlanta are the lead partners in Georgia NCORP, which includes the Georgia Center for Oncology Research and Education (Georgia CORE) in Atlanta as well as affiliates John B. Amos Cancer Center, Piedmont Columbus in Columbus; Harbin Clinic in Rome; Peyton Anderson Cancer Center, Navicent Health in Macon; Cancer Services at Northeast Georgia Medical Center in Gainesville; and Pearlman Cancer Center at South Georgia Medical Center in Valdosta.
All of these institutions enroll patients into important clinical trials that not only provide the latest treatment but will set the standard for cancer care in the future.
Clinical Cancer Trials in Local Savannah, GA
Visit the Nancy N. and J.C. Lewis Cancer & Research Pavilion Cancer Trials Database to see what trials are being planned or underway and if you or a relative might qualify.
For More Information about Cancer & NCORP Clinical Trials
For information about cancer surgical services or comprehensive cancer services and physician specialists at the Nancy N. and J.C. Lewis Cancer & Research Pavilion, please call 912-819-5704. We look forward to helping you.